Europe Microencapsulation Market To Reach $7.8 Billion By 2030

Europe Microencapsulation Market Growth & Trends

The Europe microencapsulation market size is anticipated to reach USD 7.8 billion by 2030, according to a new report by Grand View Research, Inc. The regional market is expected to expand at a CAGR of 9.9% over the forecast period. The European market is being driven by the high rate of development of the pharmaceutical, food processing, and home & personal care industries, along with increasing investments in R&D to identify new areas for market growth.

In Europe, there is a growing interest in sustainability and the environment, which is fueling demand for microencapsulation using natural and sustainable materials like biodegradable polymers and plant-based materials. Microencapsulation has become more cost-effective and efficient as a result of technological advancements, leading to its increased adoption across a variety of industries such as energy storage, textiles, and agriculture.

The increasing penetration of microencapsulation techniques in the home & personal care industry for adding fragrances and encapsulating essential oils used in personal care products is expected to drive market growth in the region. There has been a steadily increasing consumption of personal care & beauty products in Europe over the past few years.

The rising demand for functional foods from the aging population and health-conscious younger generations in Europe is expected to drive the demand for microencapsulation, to improve the flavor, fragrance, and appearance of the bioactive used in these products. According to the Italian Association of Health Products and Manufacturers, in 2021, approximately 58% of the Italian population were regular consumers of food supplements. Supplements for cardiovascular disorders, respiratory disorders, and intestinal well-being accounted for a significant share and correspondingly bolstered the demand for encapsulation in supplement manufacturing.

Market players are seeking strategies such as acquisitions, mergers, and collaborations to develop innovative and advanced solutions. For instance, in April 2022, Glanbia plc, an ingredients and services solution provider, announced the launch of TechVantage, a nutrient technology platform that is functionally optimized. The in-house technologies in the TechVantage platform are GranulPlex Granulations, UniTrit Triturations, and NutraShield Microencapsulations. TechVantage will provide customers with nutrient solutions that have improved stability, the ability to mask flavors/colors, and improved solubility/flowability.

 Request a free sample copy or view report summary: Europe Microencapsulation Market Report

Europe Microencapsulation Market Report Highlights

• The pharmaceutical & healthcare application segment accounted for 65.7% of the overall revenue share in 2022. Pharmaceutical manufacturers are competing to develop and commercialize more effective medicines and specialized and personalized treatments with a high focus on the biotechnology industry, which is expected to have a major impact on the growth of the microencapsulation market over the forecast period

• The spray technologies segment accounted for the largest revenue share of 33.7% in 2022. Spray technology is regarded as the cheapest encapsulation technology since it uses lower temperatures and has a high potential for scale-up, and it is primarily used to encapsulate minerals and vitamins, resulting in the increasing demand for the segment

• The coating technology segment is anticipated to register a CAGR of 9.4% over the forecast period. The segment is expected to grow significantly, owing to the use of microencapsulation technology for relatively large particles using the pan coating technique

• Germany dominated the regional market with a revenue share of 21.51% in 2022. The microencapsulation market in Germany is strongly influenced by the high production capacity of the pharmaceutical industry, owing to the presence of major pharmaceutical companies like Pfizer, Merck KGaA, Evonik, and many more

• Italy held a significant revenue share of 21.2% in 2022 in the European microencapsulation market. There is a significant demand for natural ingredients such as aloe vera, lavender, and essential oils in cosmetic products, which is raising the demand for microencapsulation techniques in the country

Europe Microencapsulation Market Segmentation

Grand View Research has segmented the Europe microencapsulation market based on application, technology, and region:

Europe Microencapsulation Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Healthcare Products

• Home & Personal Care

• Food & Beverages

• Agrochemicals

• Construction

• Textile

• Others

Europe Microencapsulation Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Coating

• Emulsion

• Spray Technologies

• Dripping

• Others

Europe Microencapsulation Regional Outlook (Revenue, USD Million, 2018 - 2030)

• Europe

• Germany

• U.K.

• France

• Italy

• Spain

• Russia

List of Key Players in the Europe Microencapsulation Market

• Capsulae

• LycoRed Group

• BASF SE

• Balchem

• AVEKA Group

• Reed Pacific Pty Ltd.

• GAT Microencapsulation GmbH

• Ronald T. Dodge Co.

• Evonik Industries AG

• Bayer AG